Bandingkan Harga & Kinerja Pioneerindo Gourmet International Tbk. (PTSP) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Pioneerindo Gourmet International Tbk. dan Organon Pharma Indonesia Tbk.: Pioneerindo Gourmet International Tbk. diperdagangkan di Rp1.260 (kapitalisasi pasar 273,8 M, volume 24 jam 63,3 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Pioneerindo Gourmet International Tbk. jauh lebih besar — sekitar 2,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PTSP | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 273,8 M | 104,4 M |
Volume | 63,3 rb | — |
Lot | 633 | — |
Perputaran | 78,15 jt | — |
Harga Rata-rata | 1.234,53 | — |
Nilai Transaksi | 78,15 jt | — |
Harga Ekuilibrium Indikatif | 1.240 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Pioneerindo Gourmet International Tbk.
PT Pioneerindo Gourmet International Tbk formerly Putra Sejahtera Pioneerindo is the owner and franchisor of fried chicken restaurant, California Fried Chicken. The Company also serves snacks food under the Cal Donut brand name as well as Oriental Food, known as Sapo Oriental. PT Pioneerindo Gourmet International Tbk was established based on the Notarial Deed No. 84 of Arikanti Natakusumah, S.H., dated December 13, 1983.
Selengkapnya di halaman PTSP →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
